|
|
Article: National Institutes of Health hands over WHI data to Wyeth. (Data on Combination Therapy).
- Article from:
- OB GYN News
- Article date:
- November 15, 2002
- Author:
CopyrightCOPYRIGHT 2002 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The National Institutes of Health has given unpublished data from the Women's Health Initiative to Wyeth Pharmaceuticals at the company's request, even as WHI researchers continue to analyze the findings.
"We simply plan to evaluate it and determine how it enhances the risks or benefits" of hormone replacement therapy Doug Petkus, a Wyeth spokesman, told this newspaper. Wyeth manufactures Prempro and Premarin, the two main drugs used in the WHI, a huge multicenter trial involving thousands of women.
The agency gave the data to Wyeth voluntarily after the pharmaceutical company filed a Freedom of Information Act request to obtain it. The data obtained by ...